JP2007525661A - 大分子その他の分析物の検出用生物センサー - Google Patents
大分子その他の分析物の検出用生物センサー Download PDFInfo
- Publication number
- JP2007525661A JP2007525661A JP2006543991A JP2006543991A JP2007525661A JP 2007525661 A JP2007525661 A JP 2007525661A JP 2006543991 A JP2006543991 A JP 2006543991A JP 2006543991 A JP2006543991 A JP 2006543991A JP 2007525661 A JP2007525661 A JP 2007525661A
- Authority
- JP
- Japan
- Prior art keywords
- aptamer
- epitope
- polypeptide
- construct
- label
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002521 macromolecule Polymers 0.000 title claims abstract description 33
- 150000002605 large molecules Chemical class 0.000 title claims abstract description 32
- 238000001514 detection method Methods 0.000 title claims description 60
- 108091023037 Aptamer Proteins 0.000 claims abstract description 497
- 238000000034 method Methods 0.000 claims abstract description 155
- 230000027455 binding Effects 0.000 claims abstract description 148
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 131
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 125
- 229920001184 polypeptide Polymers 0.000 claims abstract description 119
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 229960004072 thrombin Drugs 0.000 claims description 256
- 108090000190 Thrombin Proteins 0.000 claims description 249
- 230000011664 signaling Effects 0.000 claims description 119
- 239000011230 binding agent Substances 0.000 claims description 59
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 45
- 108091034117 Oligonucleotide Proteins 0.000 claims description 44
- 230000008859 change Effects 0.000 claims description 43
- 239000002773 nucleotide Substances 0.000 claims description 40
- 125000003729 nucleotide group Chemical group 0.000 claims description 38
- 230000000295 complement effect Effects 0.000 claims description 34
- 239000012491 analyte Substances 0.000 claims description 32
- 238000000338 in vitro Methods 0.000 claims description 32
- 239000000758 substrate Substances 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 25
- 102000040430 polynucleotide Human genes 0.000 claims description 25
- 108091033319 polynucleotide Proteins 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 21
- 125000006850 spacer group Chemical group 0.000 claims description 21
- 238000013459 approach Methods 0.000 claims description 15
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 108010049003 Fibrinogen Proteins 0.000 claims description 9
- 102000008946 Fibrinogen Human genes 0.000 claims description 9
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 229940012952 fibrinogen Drugs 0.000 claims description 9
- 238000002875 fluorescence polarization Methods 0.000 claims description 9
- 238000010791 quenching Methods 0.000 claims description 9
- 230000000171 quenching effect Effects 0.000 claims description 9
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 8
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 8
- 229960002897 heparin Drugs 0.000 claims description 8
- 229920000669 heparin Polymers 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 7
- 210000001519 tissue Anatomy 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000001917 fluorescence detection Methods 0.000 claims description 5
- 210000002700 urine Anatomy 0.000 claims description 5
- 206010003445 Ascites Diseases 0.000 claims description 4
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 claims description 3
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 claims description 3
- 238000000475 fluorescence cross-correlation spectroscopy Methods 0.000 claims description 3
- 238000004020 luminiscence type Methods 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000002165 resonance energy transfer Methods 0.000 claims description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims description 2
- 239000003053 toxin Substances 0.000 claims description 2
- 231100000765 toxin Toxicity 0.000 claims description 2
- 230000009878 intermolecular interaction Effects 0.000 claims 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 claims 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 claims 1
- 238000005415 bioluminescence Methods 0.000 claims 1
- 230000029918 bioluminescence Effects 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 239000008196 pharmacological composition Substances 0.000 claims 1
- 238000011002 quantification Methods 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 152
- 102000004169 proteins and genes Human genes 0.000 description 151
- 125000005647 linker group Chemical group 0.000 description 77
- 108020004414 DNA Proteins 0.000 description 51
- 238000013461 design Methods 0.000 description 42
- 238000002474 experimental method Methods 0.000 description 37
- 239000000370 acceptor Substances 0.000 description 34
- 102220568976 GTP cyclohydrolase 1_G15D_mutation Human genes 0.000 description 33
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 31
- 150000007523 nucleic acids Chemical class 0.000 description 29
- 238000003556 assay Methods 0.000 description 28
- 102000039446 nucleic acids Human genes 0.000 description 24
- 108020004707 nucleic acids Proteins 0.000 description 24
- 239000003446 ligand Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 18
- 230000004568 DNA-binding Effects 0.000 description 17
- 239000000499 gel Substances 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- 102000053602 DNA Human genes 0.000 description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 230000000875 corresponding effect Effects 0.000 description 14
- GOMLCFUVZKLQCO-HTLAMOOLSA-N thrombin aptamer Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2CO)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)[C@@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)O)C1 GOMLCFUVZKLQCO-HTLAMOOLSA-N 0.000 description 14
- 101710116602 DNA-Binding protein G5P Proteins 0.000 description 13
- 101710162453 Replication factor A Proteins 0.000 description 13
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 13
- 101710176276 SSB protein Proteins 0.000 description 13
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 13
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000035945 sensitivity Effects 0.000 description 13
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000002331 protein detection Methods 0.000 description 11
- 108010074860 Factor Xa Proteins 0.000 description 9
- 108020004682 Single-Stranded DNA Proteins 0.000 description 9
- 101150049692 THR4 gene Proteins 0.000 description 9
- 230000003993 interaction Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 230000001419 dependent effect Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 238000002189 fluorescence spectrum Methods 0.000 description 7
- 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 description 6
- 101710096438 DNA-binding protein Proteins 0.000 description 6
- 108010094028 Prothrombin Proteins 0.000 description 6
- 102100027378 Prothrombin Human genes 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229940039716 prothrombin Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 229910052693 Europium Inorganic materials 0.000 description 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000009918 complex formation Effects 0.000 description 5
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 230000005593 dissociations Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000004445 quantitative analysis Methods 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000009897 systematic effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 108091008104 nucleic acid aptamers Proteins 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 102000023888 sequence-specific DNA binding proteins Human genes 0.000 description 3
- 108091008420 sequence-specific DNA binding proteins Proteins 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- UNDAPMUKULIMSY-HGKXDEPLSA-N (4s)-4-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-carbamimidamidopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-[[(2s)-1-[[(2s,3s)-1-[[(2s,3s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[(2s)-2-[[1-[[(2s)-1-[[(2s)-1-[[(2s) Chemical compound OC(=O)C(F)(F)F.N([C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NC(CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C(C)C)C(=O)NC(C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O UNDAPMUKULIMSY-HGKXDEPLSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091008102 DNA aptamers Proteins 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 102000029797 Prion Human genes 0.000 description 2
- 108091000054 Prion Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 101100048022 Schizosaccharomyces pombe (strain 972 / ATCC 24843) prp2 gene Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- -1 analytes Polymers 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000012203 high throughput assay Methods 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000004001 molecular interaction Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 235000005749 Anthriscus sylvestris Nutrition 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108091027757 Deoxyribozyme Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 101100015729 Drosophila melanogaster drk gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 241001289753 Graphium sarpedon Species 0.000 description 1
- 101000990964 Homo sapiens Protein MIS12 homolog Proteins 0.000 description 1
- 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 101100113039 Mus musculus Cers2 gene Proteins 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 102100030327 Protein MIS12 homolog Human genes 0.000 description 1
- 101710149951 Protein Tat Proteins 0.000 description 1
- 101710082933 Single-strand DNA-binding protein Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710082247 Ubiquitin-like protein 5 Proteins 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- VJBCNMFKFZIXHC-UHFFFAOYSA-N azanium;2-(4-methyl-5-oxo-4-propan-2-yl-1h-imidazol-2-yl)quinoline-3-carboxylate Chemical compound N.N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O VJBCNMFKFZIXHC-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 101150098203 grb2 gene Proteins 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 238000004940 physical analysis method Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002821 scintillation proximity assay Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960003766 thrombin (human) Drugs 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52907603P | 2003-12-12 | 2003-12-12 | |
| PCT/US2004/041315 WO2005059509A2 (en) | 2003-12-12 | 2004-12-10 | Biosensors for detecting macromolecules and other analytes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011284014A Division JP2012115269A (ja) | 2003-12-12 | 2011-12-26 | 大分子その他の分析物の検出用生物センサー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007525661A true JP2007525661A (ja) | 2007-09-06 |
| JP2007525661A5 JP2007525661A5 (https=) | 2008-01-31 |
Family
ID=34699935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006543991A Pending JP2007525661A (ja) | 2003-12-12 | 2004-12-10 | 大分子その他の分析物の検出用生物センサー |
| JP2011284014A Pending JP2012115269A (ja) | 2003-12-12 | 2011-12-26 | 大分子その他の分析物の検出用生物センサー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011284014A Pending JP2012115269A (ja) | 2003-12-12 | 2011-12-26 | 大分子その他の分析物の検出用生物センサー |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7939313B2 (https=) |
| EP (1) | EP1692486B1 (https=) |
| JP (2) | JP2007525661A (https=) |
| CN (1) | CN101208437B (https=) |
| CA (1) | CA2545006C (https=) |
| WO (1) | WO2005059509A2 (https=) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009149549A (ja) * | 2007-12-19 | 2009-07-09 | Japan Science & Technology Agency | ペプチドアプタマーライブラリーの作製方法および用途 |
| JP2011505549A (ja) * | 2007-11-21 | 2011-02-24 | エラスムス ユニバーシティ メディカル センター ロッテルダム | 改良型fretプローブおよびその使用 |
| JP2014504299A (ja) * | 2010-12-23 | 2014-02-20 | エフ.ホフマン−ラ ロシュ アーゲー | ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用 |
| JP2014533364A (ja) * | 2011-11-11 | 2014-12-11 | イーライ・エヌ・グレザー | コバインダー補助アッセイ法 |
| WO2016047068A1 (ja) * | 2014-09-22 | 2016-03-31 | 国立研究開発法人科学技術振興機構 | ターゲット分子の検出方法及びこれに用いられるキット |
| JP2017533417A (ja) * | 2014-09-30 | 2017-11-09 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 第1及び第2のエピトープの空間的近接を検出する方法 |
| WO2019103131A1 (ja) * | 2017-11-24 | 2019-05-31 | 国立大学法人 東京大学 | アプタマーの結合部位判別方法、アプタマーペアおよび目的物質からなる三元錯体の解離定数等の測定方法並びに最適なアプタマーペアの選択方法 |
| JP2020162612A (ja) * | 2013-10-28 | 2020-10-08 | ドッツ テクノロジー コーポレイションDOTS Technology Corp. | アレルゲン検出のためのシグナル発生ポリヌクレオチド |
| JP2022551736A (ja) * | 2019-10-15 | 2022-12-13 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | 血中のアンチトロンビンiiiを定量するためのアプタマーベースのシステム |
| US11525825B2 (en) | 2014-05-15 | 2022-12-13 | Meso Scale Technologies, Llc. | Assay kits |
| US11697840B2 (en) | 2013-03-13 | 2023-07-11 | Meso Scale Technologies, Llc. | Method of detecting analyte in a sample with binding reagent, first detection reagent, and second detection reagent |
| JP2023168019A (ja) * | 2022-05-13 | 2023-11-24 | 国立大学法人北海道大学 | フォン・ヴィレブランド因子の情報を取得する方法、測定試料の調製方法及び試薬キット |
| US12163954B2 (en) | 2013-03-13 | 2024-12-10 | Meso Scale Technologies, Llc. | Assay methods |
| JP2025072414A (ja) * | 2019-06-25 | 2025-05-09 | アクトーメ ゲーエムベーハー | 2成分系の分析物を測定するための方法およびキットならびにそれらの使用 |
| US12553887B2 (en) | 2019-03-01 | 2026-02-17 | Meso Scale Technologies, Llc. | Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101208437B (zh) | 2003-12-12 | 2012-07-04 | 圣路易斯大学 | 检测大分子和其它分析物的生物传感器 |
| KR20080028886A (ko) * | 2005-05-26 | 2008-04-02 | 앙상블 디스커버리 코포레이션 | 핵산-템플레이팅된 화학 반응에 의한 생검출 |
| US7795009B2 (en) | 2005-06-15 | 2010-09-14 | Saint Louis University | Three-component biosensors for detecting macromolecules and other analytes |
| US8956857B2 (en) | 2005-06-06 | 2015-02-17 | Mediomics, Llc | Three-component biosensors for detecting macromolecules and other analytes |
| EP1907410B1 (en) | 2005-06-10 | 2012-07-04 | Saint Louis University | Methods for the selection of aptamers |
| US7811809B2 (en) | 2005-06-15 | 2010-10-12 | Saint Louis University | Molecular biosensors for use in competition assays |
| BRPI0614961A2 (pt) * | 2005-08-26 | 2016-09-13 | Archemix Corp | aptâmero, método, e, composição |
| EP2046998B1 (en) * | 2006-08-09 | 2013-10-02 | Saint Louis University | Molecular biosensors for detecting macromolecules and other analytes |
| US8664364B2 (en) * | 2007-01-24 | 2014-03-04 | Carnegie Mellon University | Optical biosensors |
| DE102007063902B3 (de) * | 2007-08-31 | 2017-11-23 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden |
| DE102007041476B4 (de) | 2007-08-31 | 2017-03-30 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden |
| US8426153B2 (en) | 2007-12-03 | 2013-04-23 | Carnegie Mellon University | Linked peptides fluorogenic biosensors |
| US20140128280A1 (en) * | 2008-04-23 | 2014-05-08 | Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behaif of Ariz | Synthetic Antibodies |
| BRPI0920985A2 (pt) * | 2008-11-21 | 2015-08-18 | Univ Columbia | Enzima de dna dividida para tipificação visual de polimorfismo de nucleotídeo único |
| EP2350657A4 (en) * | 2008-11-21 | 2013-06-12 | Univ Saint Louis | BIOSENSOR FOR DETECTING MULTIPLE EPITOPES ON ONE TARGET |
| US9040287B2 (en) | 2010-02-12 | 2015-05-26 | Mediomics, Llc | Molecular biosensors capable of signal amplification |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| HRP20151294T1 (hr) | 2010-04-05 | 2016-03-11 | Prognosys Biosciences, Inc. | Biološka testiranja sa prostornim kodiranjem |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| TWI497076B (zh) | 2010-06-25 | 2015-08-21 | Univ Nat Cheng Kung | 適合體及c-反應蛋白檢測方法 |
| EP2479914B1 (en) * | 2011-01-21 | 2015-03-04 | Alcatel Lucent | Method and transmitter element for transmitting channel information for link adaption, method and receiver element for receiving the channel information |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| FR2977674B1 (fr) * | 2011-07-06 | 2015-08-14 | Cisbio Bioassays | Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule |
| CN103160512B (zh) * | 2011-12-15 | 2014-09-24 | 国家纳米科学中心 | 一种核酸及药物载体和药物组合物及其制备方法 |
| WO2014060483A1 (en) | 2012-10-17 | 2014-04-24 | Spatial Transcriptomics Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| WO2014102803A1 (en) * | 2012-12-31 | 2014-07-03 | Yeda Research And Development Co. Ltd. | Molecular sensor and methods of use thereof |
| CN105378477B9 (zh) * | 2013-03-11 | 2021-08-06 | 梅索磅秤技术有限公司 | 用于进行多路测定法的改进方法 |
| EP3013983B1 (en) | 2013-06-25 | 2023-02-15 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
| CN103630517B (zh) * | 2013-11-15 | 2015-12-09 | 南京邮电大学 | 一种基于拆分适配体和水溶性共轭聚合物的凝血酶检测方法 |
| CN104020293A (zh) * | 2014-03-25 | 2014-09-03 | 李根喜 | 基于多肽的黑色素瘤生物标记物传感器 |
| US11639929B2 (en) | 2014-04-29 | 2023-05-02 | Yeda Research And Development Co. Ltd. | Universal histidine-tag binding compounds and methods of use thereof as fluorescent probes and sensors |
| US12332246B2 (en) | 2014-04-29 | 2025-06-17 | Yeda Research And Development Co. Ltd. | Quinoline based cyanine dye turn-on fluorescent probes and methods of use thereof |
| EP3139942B1 (en) | 2014-05-05 | 2019-12-18 | Bioventures, Llc | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| US10071087B2 (en) | 2014-07-22 | 2018-09-11 | Bioventures, Llc | Compositions and methods for selectively depleting senescent cells |
| EP2980218A1 (en) * | 2014-07-30 | 2016-02-03 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamer thrombin complex for use as an antidote to direct acting thrombin inhibitors |
| WO2016040638A2 (en) | 2014-09-10 | 2016-03-17 | Washington University | Compositions and methods for treatment of pre-cancerous skin lesions |
| WO2016040830A1 (en) | 2014-09-12 | 2016-03-17 | Mediomics, Llc | Molecular biosensors with a modular design |
| US10545158B2 (en) | 2014-12-29 | 2020-01-28 | North Carolina State University | Multiplexed diagnostic to recognize concentrations of related proteins and peptides |
| CN104569430B (zh) * | 2015-01-04 | 2017-01-04 | 深圳市艾瑞生物科技有限公司 | 一种快速定量检测心脏型脂肪酸结合蛋白的均相荧光免疫试剂组及其制备方法 |
| US10774374B2 (en) | 2015-04-10 | 2020-09-15 | Spatial Transcriptomics AB and Illumina, Inc. | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| US20180251765A1 (en) * | 2015-09-08 | 2018-09-06 | BellBrook Labs | High-throughput split aptamer screening assay |
| WO2017120589A1 (en) | 2016-01-08 | 2017-07-13 | Washington University | Compositions comprising chemerin and methods of use thereof |
| CN105543231B (zh) * | 2016-01-11 | 2019-07-05 | 河南省农业科学院农业质量标准与检测技术研究所 | 伏马毒素b1核酸适配体链置换探针的筛选及应用 |
| ES2924495T3 (es) | 2016-01-29 | 2022-10-07 | Univ Washington | GDF15 en glaucoma y métodos de uso de este |
| JP6936498B2 (ja) | 2016-04-21 | 2021-09-15 | バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーBioVentures, LLC | 抗アポトーシス性Bcl−2ファミリータンパク質の分解を誘導する化合物及びその使用 |
| WO2017189846A1 (en) | 2016-04-27 | 2017-11-02 | Thaddeus Stappenbeck | Methods for prognosing crohn's disease comprising human defensin 5 (hd5) |
| JP2019532301A (ja) * | 2016-07-15 | 2019-11-07 | イ,ジフン | 血液凝固因子検出のための化学発光バイオセンサー |
| US11058653B2 (en) | 2016-10-26 | 2021-07-13 | Washington University | Compositions comprising desaminotyrosine and uses thereof to enhance type I interferon stimulation |
| US11175296B2 (en) | 2016-10-26 | 2021-11-16 | Washington University | Methods of diagnosing and treating cancer comprising ME1 |
| EP3562953A1 (en) | 2016-12-30 | 2019-11-06 | Quidel Corporation | Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents |
| US20200000934A1 (en) | 2017-02-28 | 2020-01-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications |
| EP3743069B1 (en) | 2018-01-22 | 2025-08-06 | BioVentures, LLC | Bcl-2 proteins degraders for cancer treatment |
| US11085935B2 (en) | 2018-05-03 | 2021-08-10 | Washington University | Methods of treating based on site-specific tau phosphorylation |
| US12084423B2 (en) | 2018-05-18 | 2024-09-10 | Bioventures, Llc | Piperlongumine analogues and uses thereof |
| CN108956991B (zh) * | 2018-07-25 | 2021-04-27 | 南通大学 | 一种荧光共振能量转移生物传感器及其应用 |
| CN109444103B (zh) * | 2018-12-18 | 2021-09-28 | 咸阳师范学院 | 一种pei功能化绿色荧光碳点制备方法及基于该碳点的凝血酶检测方法 |
| EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| KR20220041072A (ko) | 2019-06-05 | 2022-03-31 | 엘아이브이 프로세스, 인크. | 클로스트리듐 디피실에 대한 앱타머 |
| US20220236257A1 (en) * | 2019-06-05 | 2022-07-28 | Yeda Research And Development Co. Ltd. | Artificial receptors, recombinant cells comprising thereof, methods for their preparation, and method of using thereof |
| WO2020252086A1 (en) | 2019-06-10 | 2020-12-17 | Washington University | Microbiota-directed foods to repair a subject's gut microbiota |
| EP4028775A4 (en) | 2019-09-10 | 2023-04-12 | Washington University | BLOOD-BASED TEST FOR DIAGNOSIS AND TREATMENT BASED ON SITE-SPECIFIC TAU PHOSPHORYLATION |
| CN110672567B (zh) * | 2019-09-26 | 2022-01-11 | 南通大学 | 低分子量肝素金纳米材料及其在乙酰肝素酶检测中的应用 |
| EP4058810A4 (en) * | 2019-11-15 | 2023-12-20 | President And Fellows Of Harvard College | DEVICE AND METHOD FOR ANALYTE DETECTION |
| WO2021150578A1 (en) * | 2020-01-20 | 2021-07-29 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Fluorescently-labeled f-actin protein biosensors and methods of high-throughput drug discovery |
| CN113624724A (zh) * | 2020-05-07 | 2021-11-09 | 廖世奇 | 一种适配体分子信标对靶分子的多元检测分析方法 |
| EP4025692A2 (en) | 2020-06-02 | 2022-07-13 | 10X Genomics, Inc. | Nucleic acid library methods |
| EP4158054B1 (en) | 2020-06-02 | 2025-04-16 | 10X Genomics, Inc. | Spatial transcriptomics for antigen-receptors |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| US11898146B2 (en) | 2020-12-03 | 2024-02-13 | Liv Process, Inc. | Aptamers against Clostridium difficile, compositions comprising aptamers against Clostridium difficile and methods of using the same |
| CN113702308B (zh) * | 2021-08-25 | 2024-01-30 | 青岛大学 | 用于大肠杆菌检测的适配体纳米比色生物传感器及应用 |
| NL2032916B1 (en) * | 2022-08-31 | 2024-03-15 | Univ Delft Tech | Single-molecule aptamer FRET for protein identification and structural analysis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002056024A2 (en) * | 2001-01-12 | 2002-07-18 | Affibody Ab | Detection methods |
| JP2003508729A (ja) * | 1999-05-14 | 2003-03-04 | ブランディーズ・ユニバーシティ | 核酸をベースとする検出 |
| WO2003078449A2 (en) * | 2001-08-13 | 2003-09-25 | Saint Louis University | A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6001577A (en) * | 1998-06-08 | 1999-12-14 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| US6127119A (en) * | 1990-06-11 | 2000-10-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
| US6147204A (en) * | 1990-06-11 | 2000-11-14 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US5683867A (en) * | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
| US5496938A (en) * | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
| US5874218A (en) * | 1990-06-11 | 1999-02-23 | Nexstar Pharmaceuticals, Inc. | Method for detecting a target compound in a substance using a nucleic acid ligand |
| US6261774B1 (en) * | 1990-06-11 | 2001-07-17 | Gilead Sciences, Inc. | Truncation selex method |
| US6030776A (en) * | 1990-06-11 | 2000-02-29 | Nexstar Pharmaceuticals, Inc. | Parallel SELEX |
| US5660985A (en) * | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US5270163A (en) * | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| US5789157A (en) * | 1990-06-11 | 1998-08-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| US5567588A (en) * | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5853984A (en) * | 1990-06-11 | 1998-12-29 | Nexstar Pharmaceuticals, Inc. | Use of nucleic acid ligands in flow cytometry |
| US5705337A (en) * | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
| US5650275A (en) * | 1990-06-11 | 1997-07-22 | Nexstar Pharmacueticals Inc | Target detection method using spectroscopically detectable nucleic acid ligands |
| US6083696A (en) * | 1990-06-11 | 2000-07-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands exponential enrichment: blended selex |
| US5637459A (en) * | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
| US5864026A (en) * | 1990-06-11 | 1999-01-26 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| US5641629A (en) * | 1990-06-11 | 1997-06-24 | Nexstar Pharmacueticals Inc | Spectroscopically detectable nucleic acid ligands |
| EP0786469B1 (en) * | 1990-06-11 | 2006-03-01 | Gilead Sciences, Inc. | Methods of use of nucleic acid ligands |
| US5723289A (en) * | 1990-06-11 | 1998-03-03 | Nexstar Pharmaceuticals, Inc. | Parallel selex |
| US6011020A (en) * | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US5763566A (en) * | 1990-06-11 | 1998-06-09 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue SELEX |
| US5476766A (en) * | 1990-06-11 | 1995-12-19 | Nexstar Pharmaceuticals, Inc. | Ligands of thrombin |
| US5543293A (en) * | 1990-06-11 | 1996-08-06 | Nexstar Pharmaceuticals, Inc. | DNA ligands of thrombin |
| US5712375A (en) * | 1990-06-11 | 1998-01-27 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| US5962219A (en) * | 1990-06-11 | 1999-10-05 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-selex |
| US5750342A (en) * | 1990-06-11 | 1998-05-12 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
| US5688935A (en) * | 1990-06-11 | 1997-11-18 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
| US5861254A (en) * | 1997-01-31 | 1999-01-19 | Nexstar Pharmaceuticals, Inc. | Flow cell SELEX |
| US6465188B1 (en) * | 1990-06-11 | 2002-10-15 | Gilead Sciences, Inc. | Nucleic acid ligand complexes |
| US5840867A (en) * | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
| US5582981A (en) * | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
| US5756291A (en) * | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
| US5998142A (en) * | 1993-09-08 | 1999-12-07 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
| US6048698A (en) * | 1994-09-20 | 2000-04-11 | Nexstar Pharmaceuticals, Inc. | Parallel SELEX™ |
| US6013443A (en) * | 1995-05-03 | 2000-01-11 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue SELEX |
| DE69633227T2 (de) * | 1995-05-03 | 2005-09-15 | Gilead Sciences, Inc., Foster City | Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex |
| US5582961A (en) * | 1995-06-06 | 1996-12-10 | Eastman Kodak Company | Photographic elements which achieve colorimetrically accurate recording |
| SE504798C2 (sv) | 1995-06-16 | 1997-04-28 | Ulf Landegren | Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten |
| US6001570A (en) * | 1997-02-18 | 1999-12-14 | Invitro Diagnostics, Inc. | Compositions, methods, kits and apparatus for determining the presence or absence of target molecules |
| US5989823A (en) * | 1998-09-18 | 1999-11-23 | Nexstar Pharmaceuticals, Inc. | Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
| EP1049803A4 (en) * | 1997-12-15 | 2002-08-21 | Nexstar Pharmaceuticals Inc | HOMOGENEOUS DETECTION OF TARGET MOLECULES BY LIGAND NUCLEIC ACID AND LIGAND BEACON INTERACTION |
| US6225058B1 (en) * | 1998-01-13 | 2001-05-01 | Invitro Diagnostics, Inc. | Compositions, methods, kits and apparatus for determining the presence or absence of target molecules |
| WO1999037806A2 (en) * | 1998-01-27 | 1999-07-29 | Cytocell Limited | Modified nucleic acid probes and uses thereof |
| US6287772B1 (en) * | 1998-04-29 | 2001-09-11 | Boston Probes, Inc. | Methods, kits and compositions for detecting and quantitating target sequences |
| US6287765B1 (en) | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
| US6399302B1 (en) * | 1998-08-21 | 2002-06-04 | University Of Virginia Patent Foundation | Signal generating oligonucleotide-based biosensor |
| US6867289B1 (en) * | 1998-10-26 | 2005-03-15 | Board Of Regents, The University Of Texas Systems | Thio-modified aptamer synthetic methods and compositions |
| US6329145B1 (en) * | 1999-02-09 | 2001-12-11 | Gilead Science, Inc. | Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand |
| US6680377B1 (en) * | 1999-05-14 | 2004-01-20 | Brandeis University | Nucleic acid-based detection |
| US6506887B1 (en) * | 1999-07-29 | 2003-01-14 | Somalogic, Incorporated | Conditional-selex |
| US20030232388A1 (en) * | 1999-09-27 | 2003-12-18 | Kreimer David I. | Beads having identifiable Raman markers |
| US7306904B2 (en) * | 2000-02-18 | 2007-12-11 | Olink Ab | Methods and kits for proximity probing |
| US20020037506A1 (en) * | 2000-04-18 | 2002-03-28 | Yun Lin | Aptamer based two-site binding assay |
| US20020022224A1 (en) * | 2000-04-28 | 2002-02-21 | Hornby David P. | Method for isolating single-stranded DNA |
| US6511809B2 (en) * | 2000-06-13 | 2003-01-28 | E. I. Du Pont De Nemours And Company | Method for the detection of an analyte by means of a nucleic acid reporter |
| US6451588B1 (en) * | 2000-06-30 | 2002-09-17 | Pe Corporation (Ny) | Multipartite high-affinity nucleic acid probes |
| US20030207271A1 (en) * | 2000-06-30 | 2003-11-06 | Holwitt Eric A. | Methods and compositions for biological sensors |
| US6380377B1 (en) | 2000-07-14 | 2002-04-30 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
| US7125660B2 (en) * | 2000-09-13 | 2006-10-24 | Archemix Corp. | Nucleic acid sensor molecules and methods of using same |
| EP1354062A2 (en) * | 2000-09-13 | 2003-10-22 | Archemix Corporation | Target activated nucleic acid biosensor and methods of using same |
| US6376190B1 (en) * | 2000-09-22 | 2002-04-23 | Somalogic, Inc. | Modified SELEX processes without purified protein |
| DE10048944A1 (de) * | 2000-10-03 | 2002-04-18 | Andreas Kage | Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren durch zweidimensionale Auftrennung |
| CA2423729A1 (en) * | 2000-10-06 | 2002-04-11 | Nugen Technologies, Inc. | Methods and probes for detection and/or quantification of nucleic acid sequences |
| AU2775402A (en) * | 2001-06-29 | 2003-01-02 | Medimolecular Pty Ltd | Nucleic acid ligands to complex targets |
| US7172865B2 (en) | 2001-08-13 | 2007-02-06 | Saint Louis University | Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors |
| US6593091B2 (en) * | 2001-09-24 | 2003-07-15 | Beckman Coulter, Inc. | Oligonucleotide probes for detecting nucleic acids through changes in flourescence resonance energy transfer |
| US20030232383A1 (en) * | 2001-11-02 | 2003-12-18 | Sylvia Daunert | Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein |
| DE10161424A1 (de) * | 2001-12-13 | 2003-07-03 | Winkler & Duennebier Ag | Verfahren und Vorrichtung zum Erkennen von Produktfehlern bei der Herstellung von Briefhüllen, Versandtaschen und dergleichen |
| US6688081B2 (en) * | 2001-12-18 | 2004-02-10 | Schmalbach-Lubeca Ag | Method for reducing headspace gas |
| CN1314810C (zh) | 2002-01-31 | 2007-05-09 | 圣路易大学 | 一种用来检测和定量核酸结合因子辅调节物的快速灵敏测定法 |
| US20030224435A1 (en) * | 2002-05-16 | 2003-12-04 | Scott Seiwert | Detection of abused substances and their metabolites using nucleic acid sensor molecules |
| US7435542B2 (en) * | 2002-06-24 | 2008-10-14 | Cornell Research Foundation, Inc. | Exhaustive selection of RNA aptamers against complex targets |
| JP4632788B2 (ja) * | 2002-09-20 | 2011-02-16 | ニュー・イングランド・バイオラブズ・インコーポレイティッド | 核酸のヘリカーゼ依存性増幅 |
| AU2003294437A1 (en) * | 2002-11-21 | 2004-06-18 | Archemix Corporation | Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| AU2004232976B2 (en) | 2003-04-18 | 2011-02-10 | Becton, Dickinson And Company | Immuno-amplification |
| US20050106594A1 (en) * | 2003-08-22 | 2005-05-19 | Andrew Ellington | In vitro selection of aptamer beacons |
| US20050095627A1 (en) * | 2003-09-03 | 2005-05-05 | The Salk Institute For Biological Studies | Multiple antigen detection assays and reagents |
| US7419835B2 (en) * | 2003-11-21 | 2008-09-02 | Palo Alto Research Center Incorporated | Screening for ligand binding at specific target sites |
| CN101208437B (zh) | 2003-12-12 | 2012-07-04 | 圣路易斯大学 | 检测大分子和其它分析物的生物传感器 |
| WO2005089524A2 (en) | 2004-03-19 | 2005-09-29 | U.S. Genomics, Inc. | Compositions and methods for detection of single molecules |
| US7795009B2 (en) * | 2005-06-15 | 2010-09-14 | Saint Louis University | Three-component biosensors for detecting macromolecules and other analytes |
| EP1907410B1 (en) | 2005-06-10 | 2012-07-04 | Saint Louis University | Methods for the selection of aptamers |
| US7811809B2 (en) * | 2005-06-15 | 2010-10-12 | Saint Louis University | Molecular biosensors for use in competition assays |
| JP5142290B2 (ja) | 2006-09-27 | 2013-02-13 | 国立大学法人東京農工大学 | 試料中の被検物質の測定方法並びにアプタマー分子及びその作出方法 |
| EP2350657A4 (en) | 2008-11-21 | 2013-06-12 | Univ Saint Louis | BIOSENSOR FOR DETECTING MULTIPLE EPITOPES ON ONE TARGET |
-
2004
- 2004-12-10 CN CN2004800368747A patent/CN101208437B/zh not_active Expired - Fee Related
- 2004-12-10 EP EP04813618.8A patent/EP1692486B1/en not_active Expired - Lifetime
- 2004-12-10 CA CA2545006A patent/CA2545006C/en not_active Expired - Fee Related
- 2004-12-10 JP JP2006543991A patent/JP2007525661A/ja active Pending
- 2004-12-10 WO PCT/US2004/041315 patent/WO2005059509A2/en not_active Ceased
- 2004-12-11 US US10/539,107 patent/US7939313B2/en not_active Expired - Fee Related
-
2010
- 2010-12-06 US US12/961,135 patent/US8592202B2/en not_active Expired - Fee Related
-
2011
- 2011-12-26 JP JP2011284014A patent/JP2012115269A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003508729A (ja) * | 1999-05-14 | 2003-03-04 | ブランディーズ・ユニバーシティ | 核酸をベースとする検出 |
| WO2002056024A2 (en) * | 2001-01-12 | 2002-07-18 | Affibody Ab | Detection methods |
| WO2003078449A2 (en) * | 2001-08-13 | 2003-09-25 | Saint Louis University | A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011505549A (ja) * | 2007-11-21 | 2011-02-24 | エラスムス ユニバーシティ メディカル センター ロッテルダム | 改良型fretプローブおよびその使用 |
| JP2009149549A (ja) * | 2007-12-19 | 2009-07-09 | Japan Science & Technology Agency | ペプチドアプタマーライブラリーの作製方法および用途 |
| JP2014504299A (ja) * | 2010-12-23 | 2014-02-20 | エフ.ホフマン−ラ ロシュ アーゲー | ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用 |
| US11242570B2 (en) | 2011-11-11 | 2022-02-08 | Meso Scale Technologies, Llc. | Co-binder assisted assay methods |
| JP2020126068A (ja) * | 2011-11-11 | 2020-08-20 | イーライ・エヌ・グレザー | コバインダー補助アッセイ法 |
| US12359264B2 (en) | 2011-11-11 | 2025-07-15 | Meso Scale Technologies, Llc. | Co-binder assisted assay methods |
| US9777338B2 (en) | 2011-11-11 | 2017-10-03 | Meso Scale Technologies, Llc. | Co-binder assisted assay methods |
| JP2018054629A (ja) * | 2011-11-11 | 2018-04-05 | イーライ・エヌ・グレザー | コバインダー補助アッセイ法 |
| JP2014533364A (ja) * | 2011-11-11 | 2014-12-11 | イーライ・エヌ・グレザー | コバインダー補助アッセイ法 |
| US12163954B2 (en) | 2013-03-13 | 2024-12-10 | Meso Scale Technologies, Llc. | Assay methods |
| US11697840B2 (en) | 2013-03-13 | 2023-07-11 | Meso Scale Technologies, Llc. | Method of detecting analyte in a sample with binding reagent, first detection reagent, and second detection reagent |
| JP6992126B2 (ja) | 2013-10-28 | 2022-02-03 | ドッツ テクノロジー コーポレイション | アレルゲン検出のためのシグナル発生ポリヌクレオチド |
| JP2020162612A (ja) * | 2013-10-28 | 2020-10-08 | ドッツ テクノロジー コーポレイションDOTS Technology Corp. | アレルゲン検出のためのシグナル発生ポリヌクレオチド |
| US11268136B2 (en) | 2013-10-28 | 2022-03-08 | Dots Technology Corp. | Allergen detection |
| US12411131B2 (en) | 2014-05-15 | 2025-09-09 | Meso Scale Technologies, Llc. | Assay methods |
| US11525825B2 (en) | 2014-05-15 | 2022-12-13 | Meso Scale Technologies, Llc. | Assay kits |
| JP2025020158A (ja) * | 2014-05-15 | 2025-02-12 | メソ スケール テクノロジーズ エルエルシー | 改善されたアッセイ方法 |
| KR102461615B1 (ko) * | 2014-09-22 | 2022-11-01 | 고쿠리츠켄큐카이하츠호진 카가쿠기쥬츠신코키코 | 타겟 분자의 검출 방법 및 이것에 사용되는 키트 |
| WO2016047068A1 (ja) * | 2014-09-22 | 2016-03-31 | 国立研究開発法人科学技術振興機構 | ターゲット分子の検出方法及びこれに用いられるキット |
| JPWO2016047068A1 (ja) * | 2014-09-22 | 2017-07-06 | 国立研究開発法人科学技術振興機構 | ターゲット分子の検出方法及びこれに用いられるキット |
| KR20170057241A (ko) * | 2014-09-22 | 2017-05-24 | 고쿠리츠켄큐카이하츠호진 카가쿠기쥬츠신코키코 | 타겟 분자의 검출 방법 및 이것에 사용되는 키트 |
| JP2017533417A (ja) * | 2014-09-30 | 2017-11-09 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 第1及び第2のエピトープの空間的近接を検出する方法 |
| WO2019103131A1 (ja) * | 2017-11-24 | 2019-05-31 | 国立大学法人 東京大学 | アプタマーの結合部位判別方法、アプタマーペアおよび目的物質からなる三元錯体の解離定数等の測定方法並びに最適なアプタマーペアの選択方法 |
| US12553887B2 (en) | 2019-03-01 | 2026-02-17 | Meso Scale Technologies, Llc. | Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same |
| JP2025072414A (ja) * | 2019-06-25 | 2025-05-09 | アクトーメ ゲーエムベーハー | 2成分系の分析物を測定するための方法およびキットならびにそれらの使用 |
| JP7621666B2 (ja) | 2019-10-15 | 2025-01-27 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | 血中のアンチトロンビンiiiを定量するためのアプタマーベースのシステム |
| JP2022551736A (ja) * | 2019-10-15 | 2022-12-13 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | 血中のアンチトロンビンiiiを定量するためのアプタマーベースのシステム |
| JP2023168019A (ja) * | 2022-05-13 | 2023-11-24 | 国立大学法人北海道大学 | フォン・ヴィレブランド因子の情報を取得する方法、測定試料の調製方法及び試薬キット |
| JP7832621B2 (ja) | 2022-05-13 | 2026-03-18 | 国立大学法人北海道大学 | フォン・ヴィレブランド因子の情報を取得する方法、測定試料の調製方法及び試薬キット |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1692486A2 (en) | 2006-08-23 |
| US20110091893A1 (en) | 2011-04-21 |
| CN101208437B (zh) | 2012-07-04 |
| US7939313B2 (en) | 2011-05-10 |
| CN101208437A (zh) | 2008-06-25 |
| CA2545006A1 (en) | 2005-06-30 |
| EP1692486A4 (en) | 2008-05-21 |
| WO2005059509A3 (en) | 2007-11-15 |
| HK1120568A1 (en) | 2009-04-03 |
| US20060110739A1 (en) | 2006-05-25 |
| US8592202B2 (en) | 2013-11-26 |
| CA2545006C (en) | 2013-09-17 |
| EP1692486B1 (en) | 2015-10-28 |
| WO2005059509A2 (en) | 2005-06-30 |
| JP2012115269A (ja) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1692486B1 (en) | Biosensors for detecting macromolecules and other analytes | |
| US7795009B2 (en) | Three-component biosensors for detecting macromolecules and other analytes | |
| US7811809B2 (en) | Molecular biosensors for use in competition assays | |
| US8956857B2 (en) | Three-component biosensors for detecting macromolecules and other analytes | |
| Tang et al. | In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection | |
| Ilgu et al. | Aptamers in analytics | |
| Ebrahimi et al. | Forced intercalation (FIT)-aptamers | |
| Tombelli et al. | Analytical applications of aptamers | |
| AU784335B2 (en) | Signaling aptamers that transduce molecular recognition to differential signal | |
| JP2007525661A5 (https=) | ||
| Nie et al. | A self-assemble aptamer fragment/target complex based high-throughput colorimetric aptasensor using enzyme linked aptamer assay | |
| CA2660129C (en) | Molecular biosensors for detecting macromolecules and other analytes | |
| US20220243196A1 (en) | Screening method of aptamer and immunoassay using the aptamer | |
| Tombelli et al. | Aptamers biosensors for pharmaceutical compounds | |
| CN112424371A (zh) | 蛋白质-多核苷酸缀合物的检测测定 | |
| HK1120568B (en) | Biosensors for detecting macromolecules and other analytes | |
| AU2006226844A1 (en) | Elucidation of high affinity, high specificity oligonucleotides and derivatized oligonucleotide sequences for target recognition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071127 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071127 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100223 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100524 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100531 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100823 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101124 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110223 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110302 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110524 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110823 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111226 |